Video Experimental Relacionado

Updated: Jan 18, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.5K

Mejorar la regresión de la aterosclerosis en ratones diabéticos a través de Apo AI (Apolipoproteína AI)

Daniel J Rader1

  • 1Departments of Genetics, Medicine, and Pediatrics, and the Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

Circulation
|October 1, 2019
PubMed
Resumen

No abstract available in PubMed .

Palabras clave:
Los editorialesApolipoproteína A.I. y sus derivadoscolesterol y HDLDiabetes mellitus, en fase experimentalLas lipoproteínas, HDLLas lipoproteínas, las LDL

Más Videos Relacionados

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

40.1K
A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision05:47

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

Published on: May 13, 2021

4.2K

Videos de Conceptos Relacionados

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322